BioCryst Pharmaceuticals, Inc. (BCRX) vs Prestige Consumer Healthcare Inc. (PBH)
- BioCryst Pharmaceuticals, Inc. BCRX 7.79 −2.87%
- Prestige Consumer Healthcare Inc. PBH 49.92 +1.46%
BioCryst Pharmaceuticals, Inc. and Prestige Consumer Healthcare Inc. are both Drug Manufacturers Specialty & Generic companies. Prestige Consumer Healthcare Inc. is the larger, with a market value of $2.3B against $2.1B — 1.1× the size. BioCryst Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Prestige Consumer Healthcare Inc. trades at 13.9×. BioCryst Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 68.7% against −1.36%. Prestige Consumer Healthcare Inc. has the higher net margin (15.6% vs −40.9%) and the higher return on invested capital (4.70% vs −610.6%). Across the 19 metrics below, BioCryst Pharmaceuticals, Inc. leads on 12 and Prestige Consumer Healthcare Inc. on 7.
Valuation
Profitability
| Metric | BCRX | PBH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 97.78% | 53.53% | 53.94% |
| Operating margin | (33.29%) | 26.26% | 0.00% |
| Net margin | (40.90%) | 15.57% | 0.00% |
| Free cash flow margin | 39.75% | 21.30% | 0.00% |
| Return on equity | 87.84% | 9.12% | (0.40%) |
| Return on assets | (75.79%) | 4.30% | (3.32%) |
| Return on invested capital | (610.55%) | 4.70% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack